Compare EVO & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | NABL |
|---|---|---|
| Founded | 1993 | 2000 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 945.6M |
| IPO Year | N/A | 2021 |
| Metric | EVO | NABL |
|---|---|---|
| Price | $2.76 | $3.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $7.00 | ★ $8.31 |
| AVG Volume (30 Days) | 95.9K | ★ 1.1M |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $511,430,000.00 |
| Revenue This Year | $1.37 | $11.04 |
| Revenue Next Year | $10.05 | $8.53 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.71 |
| 52 Week Low | $2.31 | $3.24 |
| 52 Week High | $4.80 | $9.04 |
| Indicator | EVO | NABL |
|---|---|---|
| Relative Strength Index (RSI) | 41.07 | 29.45 |
| Support Level | $2.32 | N/A |
| Resistance Level | $3.78 | $5.22 |
| Average True Range (ATR) | 0.09 | 0.34 |
| MACD | -0.06 | -0.21 |
| Stochastic Oscillator | 19.16 | 13.21 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.